These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28902718)

  • 61. Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention.
    Bezerra HG; Attizzani GF; Sirbu V; Musumeci G; Lortkipanidze N; Fujino Y; Wang W; Nakamura S; Erglis A; Guagliumi G; Costa MA
    JACC Cardiovasc Interv; 2013 Mar; 6(3):228-36. PubMed ID: 23517833
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Peri-strut low-intensity areas in optical coherence tomography correlate with peri-strut inflammation and neointimal proliferation: an in-vivo correlation study in the familial hypercholesterolemic coronary swine model of in-stent restenosis.
    Tellez A; Afari ME; Buszman PP; Seifert P; Cheng Y; Milewski K; McGregor JC; Garza JA; Roberts MB; Yi GH; Kaluza GL; Granada JF
    Coron Artery Dis; 2014 Nov; 25(7):595-601. PubMed ID: 25013949
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.
    Mizoguchi T; Sawada T; Shinke T; Yamada S; Okamoto H; Kim SS; Takarada A; Yasaka Y
    Int J Cardiol; 2014 Feb; 171(2):224-30. PubMed ID: 24388538
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coronary angioscopy and optical coherence tomography for confirmation of drug-coated neointimal plaque after paclitaxel-coated balloon angioplasty for in-stent restenosis.
    Yoneyama K; Koyama K; Tanabe Y; Mitarai T; Kamijima R; Kuwata S; Yamazaki H; Nakano E; Kongoji K; Harada T; Akashi YJ
    Int J Cardiol; 2014 Oct; 176(3):1207-9. PubMed ID: 25129263
    [No Abstract]   [Full Text] [Related]  

  • 65. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
    Kleber FX; Schulz A; Waliszewski M; Hauschild T; Böhm M; Dietz U; Cremers B; Scheller B; Clever YP
    Clin Res Cardiol; 2015 Mar; 104(3):217-25. PubMed ID: 25349065
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preclinical evaluation of a paclitaxel-incorporated nanoparticle-coated balloon in rabbit and porcine models.
    Yamamoto E; Watanabe S; Bao B; Watanabe H; Nakatsuma K; Izuhara M; Ono K; Nakazawa G; Kimura T; Saito N
    Cardiovasc Revasc Med; 2018 Jun; 19(4):433-437. PubMed ID: 29174499
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.
    Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.
    Yamaguchi H; Arikawa R; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):32-5. PubMed ID: 25617940
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Unusually aggressive immature neo-intimal hyperplasia causing in-stent restenosis.
    McCutcheon K; Triantafyllis AS; Bennett J; Adriaenssens T
    Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):404-405. PubMed ID: 29019519
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy.
    Kagawa Y; Shiode N; Kawase T; Tamekiyo H; Okimoto T; Hayashi Y
    Cardiovasc Interv Ther; 2017 Apr; 32(2):170-173. PubMed ID: 26979600
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation.
    Komatsu T; Yaguchi I; Komatsu S; Nakahara S; Kobayashi S; Sakai Y; Taguchi I
    Tex Heart Inst J; 2015 Aug; 42(4):327-32. PubMed ID: 26413014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 3D optical coherence tomography: new insights into the process of optimal rewiring of side branches during bifurcational stenting.
    Okamura T; Onuma Y; Yamada J; Iqbal J; Tateishi H; Nao T; Oda T; Maeda T; Nakamura T; Miura T; Yano M; Serruys PW
    EuroIntervention; 2014 Dec; 10(8):907-15. PubMed ID: 24531393
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound.
    Fujino Y; Bezerra HG; Attizzani GF; Wang W; Yamamoto H; Chamié D; Kanaya T; Mehanna E; Tahara S; Nakamura S; Costa MA
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E173-83. PubMed ID: 23359350
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study.
    Merinopoulos I; Gunawardena T; Wickramarachchi U; Richardson P; Maart C; Sreekumar S; Sawh C; Wistow T; Sarev T; Ryding A; Gilbert T; Perperoglou A; Vassiliou VS; Eccleshall SC
    Clin Res Cardiol; 2021 Feb; 110(2):220-227. PubMed ID: 32876814
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation.
    Radu MD; Räber L; Heo J; Gogas BD; Jørgensen E; Kelbæk H; Muramatsu T; Farooq V; Helqvist S; Garcia-Garcia HM; Windecker S; Saunamäki K; Serruys PW
    EuroIntervention; 2014 Jan; 9(9):1085-94. PubMed ID: 24064426
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multiple Mechanisms in 1 In-Stent Restenosis Assessed by Optical Coherence Tomography.
    Lu WD; Huang CW; Li YH; Chen JY
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2340-2341. PubMed ID: 29102578
    [No Abstract]   [Full Text] [Related]  

  • 80. Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells.
    Nicol P; Hoppman P; Euller K; Xhepa E; Lenz T; Rai H; Jinnouchi H; Bulin A; Castellanos MI; Lahmann AL; Koppara T; Kastrati A; Joner M
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):25-35. PubMed ID: 32761285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.